Regulation of Serum Sodium Levels during Chemotherapy Using Selective Arginine Vasopressin V2-Receptor Antagonist Tolvaptan in a Four-Year-Old Girl with a Suprasellar Germ Cell Tumor

Regulation of Serum Sodium Levels during Chemotherapy Using Selective Arginine Vasopressin V2-Receptor Antagonist Tolvaptan in a Four-Year-Old Girl with a Suprasellar Germ Cell Tumor

There are limited reports on the use of tolvaptan for syndrome of inappropriate antidiuretic hormone secretion (SIADH) in children. Managing serum sodium levels in SIADH patients during chemotherapy is often difficult because of the need for massive fluid infusions. We report the course of the use o...

Full description

Bibliographic Details
Main Authors: Shota Hiroshima, Hiromi Nyuzuki, Sunao Sasaki, Yohei Ogawa, Keisuke Nagasaki
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Children
Subjects:
tolvaptan
hyponatremia
pediatric SIADH
germ cell tumor
chemotherapy
Online Access:https://www.mdpi.com/2227-9067/8/4/293

Internet

https://www.mdpi.com/2227-9067/8/4/293

Similar Items